The 21st International AIDS Conference (AIDS 2016) will highlight the latest discoveries in clinical care. The greatest breakthroughs in HIV science have emerged thanks to the tireless efforts of clinical researchers and physicians working together to build the evidence base supporting new treatment approaches to improve the clinical management of people at risk for and living with HIV.

Take a look below at some of the exciting AIDS 2016 highlights in clinical science and we look forward to seeing you in Durban.


Conference Session Highlights

Highlights from some of the sessions, meetings, and speakers include: 
  • Pre-conference Global HIV Forum on Integrase Inhibitors, blending science and clinical practice to help HIV clinicians and healthcare professionals enhance their ability to interpret the latest research and apply it in their daily work
  • 3rd International HIV / Viral Hepatitis Co-infection Meeting, focused on increasing optimal treatment of viral hepatitis in people living with HIV, and finding creative solutions to increase access to treatments while supporting continued innovation, with speakers including Jürgen Rockstroh, University of Bonn and Marina Klein, McGill University
  • TB2016, a two-day conference focused exclusively on tuberculosis—the world’s deadliest communicable disease—co-chaired by Haileyesus Getahun, WHO, Jens Lundgren, University of Copenhagen, and Valerie Mizrahi, University of Cape Town
  • Several noteworthy plenaries, including “TB and Co-infections, Co-morbidities: The Long Game” by Anton Pozniak, Chelsea and Westminster Hospital; “Universal Access: Systems for Health in the Immediate Treatment Era” by Alex Coutinho, Accordia Global Health Foundation; “Towards a New Treatment Era?: Translating Results from START and TEMPRANO to Clinical Practice” by Serge Paul Eholié, Treichville University Teaching Hospital; and closing plenary by Carlos del Rio on the use of innovative approaches to HIV diagnosis, treatment and prevention

Scientific Programme Highlights

Programme highlights with some of the latest scientific findings include: 
  • New insights from the START trial that shed light on decisions of which patients will benefit most from immediate HIV treatment 
  • The latest results from trials of new direct-acting agents for hepatitis C for patients with HIV-HCV co-infection
  • Latest findings from randomized PrEP clinical trials and demonstration projects, highlighting best practices, implementation challenges, and longer term outcomes
  • Key learnings on integrated treatment and prevention strategies to eliminate HIV transmission among sero-discordant couples 
  • New findings on pregnancy outcomes of women acquiring HIV perinatally (PHIV) compared to women acquiring HIV non-perinatally
  • Randomized trial results on HIV testing to increase diagnoses among men who have sex with men in Australia, India, and Kenya 
  • A promising new strategy to better improve ART-adherence and retention among adolescents and young adults
  • New discoveries in diagnosis and treatment of tuberculosis in patients with HIV
Copyright © 2016 International AIDS Society, All rights reserved.